Polymeric Nanoparticles for Oral, Parenteral and Transdermal Drug Delivery: Design Principles, Performance Optimization, and Translational Challenges

The increasing complexity of modern therapeutic agents, including poorly water-soluble drugs, macromolecules, peptides, and nucleic acids, has highlighted the limitations of traditional drug delivery approaches. Nanoparticle-based drug delivery systems have emerged as a powerful strategy to overcome these challenges by enabling precise control over drug protection, transport, and release. At the nanoscale, carriers can interact more effectively with biological membranes, enhance cellular uptake, and modulate pharmacokinetic and pharmacodynamic profiles. Polymeric nanoparticles, in particular, offer structural versatility and functional adaptability, making them suitable for addressing diverse therapeutic and physiological requirements across multiple routes of administration.^1-4

Limitations of Conventional Dosage Forms (Oral, Injectable, and Transdermal)

Conventional oral dosage forms often suffer from low and variable bioavailability due to poor aqueous solubility, chemical or enzymatic degradation in the gastrointestinal tract, limited intestinal permeability, and extensive first-pass metabolism. Injectable formulations, while bypassing gastrointestinal barriers, present their own limitations such as rapid systemic clearance, non-specific biodistribution, frequent dosing requirements, and risks associated with invasive administration, including infection and patient non-compliance. Similarly, traditional transdermal systems are constrained by the highly efficient barrier function of the stratum corneum, restricting drug permeation primarily to low-molecular-weight, lipophilic compounds. These limitations collectively reduce therapeutic efficiency and highlight the need for advanced delivery systems capable of improving drug performance and patient outcomes.

Advantages of Polymeric Nanoparticles over Lipid and Inorganic Systems^5-7

Polymeric nanoparticles offer several advantages over lipid-based and inorganic nanocarriers. Unlike lipid nanoparticles, polymeric systems provide superior mechanical stability, controlled degradation kinetics, and broader compatibility with both hydrophilic and hydrophobic drugs. In contrast to inorganic nanoparticles, polymeric carriers are generally biodegradable and biocompatible, reducing concerns related to long-term accumulation and chronic toxicity. Additionally, polymer chemistry allows precise tailoring of particle size, surface charge, hydrophilicity, and functionalization with targeting ligands or stimuli-responsive moieties. This design flexibility enables polymeric nanoparticles to achieve sustained drug release, improved targeting efficiency, and enhanced safety profiles, making them highly attractive for clinical translation.

Novelty and Justification for Route-Specific Design and Translational Focus

A key novelty of this review lies in its route-specific evaluation of polymeric nanoparticle design, recognizing that each route of administration presents distinct anatomical, physiological, and biochemical barriers. Rather than adopting a generalized approach, this review systematically correlates nanoparticle design attributes with route-dependent performance requirements, such as gastrointestinal stability for oral delivery, prolonged circulation for parenteral delivery, and enhanced skin penetration for transdermal delivery. In addition, the review emphasizes translational challenges, including scalability, regulatory considerations, and clinical feasibility, which are often underrepresented in academic discussions. This dual focus on route-tailored design and real-world translation provides a meaningful framework for guiding future research and accelerating the clinical adoption of polymeric nanoparticle-based therapeutics.^8-10

Table 1. Key Limitations of Conventional Dosage Forms and Advantages Offered by Polymeric Nanoparticles

The present review aims to provide a comprehensive and critical analysis of polymeric nanoparticles as advanced drug delivery platforms for oral, parenteral, and transdermal administration. It focuses on fundamental design principles, formulation strategies, and performance optimization approaches that govern nanoparticle behavior in biological environments. Furthermore, the review examines how physicochemical properties of polymeric nanoparticles influence drug release, biodistribution, and therapeutic efficacy across different delivery routes. By integrating formulation science with biological and translational perspectives, this review seeks to offer a holistic understanding of polymeric nanoparticle-based drug delivery systems.

Polymeric Nanoparticles in Drug Delivery^11-15

Polymeric nanoparticles are submicron-sized colloidal systems, typically ranging from 10 to 1000 nm, composed of natural or synthetic polymers that serve as carriers for therapeutic agents. Depending on their internal architecture, polymeric nanoparticles may be classified as nanospheres, in which the drug is uniformly dispersed or adsorbed within a polymeric matrix, or nanocapsules, where the drug is confined within a core surrounded by a polymeric shell. Their small size and high surface-area-to-volume ratio enable intimate interaction with biological membranes, facilitating improved drug absorption, cellular internalization, and controlled release. Key physicochemical attributes such as particle size, surface charge, hydrophobicity, and polymer composition critically influence their biological performance and therapeutic outcomes.

Structural Versatility and Drug Encapsulation Capability

One of the defining advantages of polymeric nanoparticles is their capacity to encapsulate a wide range of therapeutic molecules, including hydrophobic drugs, hydrophilic compounds, proteins, peptides, and nucleic acids. Drug incorporation may occur through physical entrapment, adsorption, or chemical conjugation, depending on the polymer characteristics and formulation strategy. This structural versatility allows polymeric nanoparticles to protect labile drugs from premature degradation, mask unfavorable physicochemical properties, and provide sustained or stimuli-responsive drug release. Consequently, polymeric nanoparticles can be rationally engineered to address specific therapeutic challenges associated with different routes of administration.

Biodegradability and Biocompatibility Considerations

Biodegradability and biocompatibility are essential prerequisites for the successful clinical translation of nanoparticle-based drug delivery systems. Many polymers used in nanoparticle fabrication undergo controlled degradation into non-toxic byproducts that are readily eliminated from the body through natural metabolic pathways. This property minimizes long-term accumulation and systemic toxicity, which are common concerns associated with non-degradable inorganic nanocarriers. Furthermore, the surface chemistry of polymeric nanoparticles can be modified to reduce immunogenicity and improve hemocompatibility, thereby enhancing their safety profile for repeated or chronic administration.^16-17

Surface Functionalization and Targeting Potential

The surface of polymeric nanoparticles provides a versatile platform for functionalization with hydrophilic polymers, targeting ligands, or stimuli-responsive groups. Surface modification strategies such as PEGylation can improve colloidal stability, reduce opsonization, and prolong systemic circulation time following parenteral administration. In addition, the attachment of ligands such as peptides, antibodies, or sugars enables receptor-mediated targeting, enhancing site-specific drug delivery and reducing off-target effects. This ability to fine-tune surface properties distinguishes polymeric nanoparticles from many conventional delivery systems and contributes significantly to their therapeutic efficiency.

Role of Polymeric Nanoparticles in Modern Drug Delivery

In contemporary pharmaceutical research, polymeric nanoparticles are increasingly recognized as multifunctional platforms capable of integrating drug delivery, targeting, and controlled release within a single system. Their adaptability makes them suitable for oral, parenteral, and transdermal routes, each of which imposes unique biological constraints. By tailoring polymer composition and nanoparticle architecture, it is possible to design delivery systems that optimize drug stability, absorption, and therapeutic performance. As a result, polymeric nanoparticles represent a central component of next-generation drug delivery strategies aimed at improving clinical efficacy and patient compliance.^18-19

Table 2. General Characteristics and Functional Attributes of Polymeric Nanoparticles

 Polymers Used in Nanoparticle Fabrication^20-27

The selection of an appropriate polymer is a critical determinant in the successful design of polymeric nanoparticles, as it directly influences drug loading capacity, release kinetics, stability, biocompatibility, and in vivo performance. Polymers employed for nanoparticle fabrication are broadly derived from natural, synthetic, or chemically modified sources, each offering distinct physicochemical and biological advantages. The choice of polymer is governed by factors such as the nature of the drug, intended route of administration, desired release profile, and translational feasibility. An optimal polymeric system must ensure compatibility with the encapsulated drug while maintaining safety and functional integrity within biological environments. Natural polymers have gained considerable attention due to their inherent biocompatibility, biodegradability, and minimal toxicity. Polymers such as chitosan, alginate, gelatin, and dextran are widely explored for nanoparticle fabrication because of their ability to interact favourably with biological tissues. These materials often exhibit mucoadhesive properties, making them particularly suitable for oral and transdermal drug delivery. Additionally, the presence of functional groups within natural polymers allows facile chemical modification, enabling enhanced drug loading, controlled release, and improved targeting. However, batch-to-batch variability and limited mechanical strength may restrict their large-scale pharmaceutical application. Synthetic polymers are extensively used in polymeric nanoparticle systems due to their reproducible quality, tunable physicochemical properties, and well-defined degradation behavior. Polymers such as poly (lactic acid), poly (lactic-co-glycolic acid), and polycaprolactone are among the most widely investigated materials for drug delivery applications. These polymers undergo predictable hydrolytic degradation, allowing precise modulation of drug release kinetics over extended periods. Their mechanical stability and compatibility with various fabrication techniques make them suitable for industrial-scale production. Moreover, several synthetic polymers have received regulatory approval, further supporting their translational potential. In recent years, the development of functional and stimuli-responsive polymers has expanded the scope of polymeric nanoparticles in advanced drug delivery. These polymers are designed to respond to specific physiological triggers such as pH, temperature, redox conditions, or enzymatic activity, enabling site-specific and on-demand drug release. Such smart polymeric systems are particularly advantageous for targeted therapies, including cancer and inflammatory diseases, where controlled drug release at the pathological site is crucial. The incorporation of functional polymers also facilitates surface engineering, enhancing cellular uptake and therapeutic specificity. Overall, the rational selection and design of polymers play a pivotal role in determining the performance and clinical success of polymeric nanoparticles. Balancing biocompatibility, stability, drug release control, and manufacturability remains a central challenge in polymer selection. Continued advancements in polymer chemistry and material science are expected to further enhance the versatility and effectiveness of polymeric nanoparticles, enabling their broader application across diverse drug delivery routes.

Table 3. Common Polymers Used in Polymeric Nanoparticle Fabrication and Their Key Attributes

Preparation Techniques of Polymeric Nanoparticles^28-41

Emulsion–Solvent Evaporation Method

The emulsion–solvent evaporation technique is one of the most widely employed methods for the preparation of polymeric nanoparticles, particularly for hydrophobic drugs. In this method, the polymer and drug are dissolved in a volatile organic solvent, which is then emulsified into an aqueous phase containing a suitable stabilizer or surfactant. Upon continuous stirring or homogenization, the organic solvent gradually evaporates, leading to polymer precipitation and nanoparticle formation. This method allows good control over particle size and drug loading by adjusting formulation and process variables such as polymer concentration, surfactant type, and stirring speed. However, the use of organic solvents and challenges related to complete solvent removal may limit its applicability for sensitive biomolecules.

Nanoprecipitation (Solvent Displacement) Method

Nanoprecipitation, also known as solvent displacement, is a simple and rapid method commonly used for the preparation of polymeric nanoparticles loaded with hydrophobic or moderately lipophilic drugs. In this approach, the polymer and drug are dissolved in a water-miscible organic solvent and subsequently added to an aqueous phase under controlled stirring. Rapid diffusion of the solvent into the aqueous phase causes supersaturation and spontaneous formation of nanoparticles. This method does not require high energy input or complex equipment, making it attractive for laboratory-scale formulation. Nevertheless, its application is often restricted by lower drug encapsulation efficiency for highly water-soluble drugs.

Ionic Gelation Method

The ionic gelation technique is primarily used for nanoparticles prepared from polyelectrolyte polymers, particularly natural polymers such as chitosan. This method relies on electrostatic interactions between oppositely charged polymers and crosslinking agents, resulting in nanoparticle formation under mild conditions. Ionic gelation is especially advantageous for encapsulating proteins, peptides, and nucleic acids, as it avoids harsh solvents and high temperatures. The mild processing conditions contribute to the preservation of biological activity, although controlling particle size distribution and long-term stability can be challenging.

Emulsion–Solvent Diffusion Method

The emulsion–solvent diffusion method is a modified version of the emulsion-based approach, designed to enhance nanoparticle uniformity and reduce solvent-related issues. In this method, a partially water-miscible solvent system is used, allowing controlled diffusion of the solvent from the internal phase to the external aqueous phase. This controlled diffusion leads to gradual polymer precipitation and formation of nanoparticles with relatively narrow size distribution. The method is suitable for both hydrophilic and hydrophobic drugs but requires careful optimization of solvent composition and process parameters.

Spray Drying Technique

Spray drying is a scalable and industrially feasible technique for producing polymeric nanoparticles, particularly in the form of dry powders. In this method, a polymer–drug solution or suspension is atomized into a hot drying chamber, where rapid solvent evaporation results in nanoparticle formation. Spray drying offers advantages such as short processing time, continuous operation, and ease of scale-up. However, exposure to elevated temperatures may pose limitations for thermolabile drugs, and particle aggregation may occur if formulation conditions are not adequately optimized.

High-Pressure Homogenization

High-pressure homogenization is a top-down approach used to reduce particle size by applying intense shear forces and cavitation. In this technique, a polymer–drug dispersion is forced through a narrow gap under high pressure, resulting in the breakdown of larger particles into nanosized systems. This method is advantageous for producing nanoparticles with relatively uniform size and is suitable for large-scale manufacturing. Nonetheless, the high energy input and mechanical stress may affect the stability of sensitive drug molecules.

Microfluidics-Based Fabrication

Microfluidics-based nanoparticle preparation represents a modern and highly controlled approach for polymeric nanoparticle fabrication. This technique utilizes micro-scale channels to precisely control the mixing of polymer and aqueous phases, enabling reproducible and narrowly distributed nanoparticles. Microfluidic systems offer exceptional control over particle size, morphology, and drug loading, making them attractive for personalized medicine and advanced drug delivery research. Despite these advantages, high equipment costs and limited throughput currently restrict their widespread industrial application.

Comparative Perspective on Preparation Techniques

Each preparation technique offers unique advantages and limitations in terms of scalability, drug compatibility, and process control. Selection of an appropriate method depends on the physicochemical nature of the drug, polymer characteristics, desired particle attributes, and intended route of administration. A thorough understanding of these methods is essential for rational formulation design and successful translation of polymeric nanoparticles from laboratory research to clinical applications.

Table 4. Preparation Techniques for Polymeric Nanoparticles

Physicochemical Characterization of Polymeric Nanoparticles^42-54

Particle Size and Size Distribution

Particle size is one of the most critical parameters influencing the biological performance of polymeric nanoparticles, as it governs cellular uptake, biodistribution, clearance, and drug release behavior. Nanoparticles intended for oral delivery must be sufficiently small to facilitate intestinal uptake, while parenteral formulations require narrow size distribution to ensure predictable circulation and minimize embolic risks. Size distribution is commonly expressed as the polydispersity index, which reflects formulation homogeneity. A low polydispersity index indicates uniform particle populations and is generally preferred for reproducible therapeutic performance and regulatory acceptance.

Zeta Potential and Surface Charge

Zeta potential provides an indirect measure of surface charge and is a key indicator of colloidal stability. Nanoparticles with high positive or negative zeta potential values tend to repel each other, reducing aggregation during storage and administration. Surface charge also plays a significant role in biological interactions, influencing mucoadhesion, protein adsorption, and cellular uptake. Positively charged nanoparticles often exhibit enhanced interaction with negatively charged biological membranes, whereas neutral or slightly negative particles may demonstrate prolonged systemic circulation following parenteral administration.

Morphological Characteristics

The shape and surface morphology of polymeric nanoparticles significantly impact their interaction with biological systems. Spherical nanoparticles are generally favored due to their predictable flow properties and uniform cellular uptake. Morphological evaluation provides insights into particle integrity, surface smoothness, and aggregation tendencies. Structural uniformity is particularly important for controlled drug release and batch-to-batch reproducibility. Irregular or aggregated particles may compromise stability, alter release profiles, and reduce therapeutic efficiency.

Drug Loading and Encapsulation Efficiency

Drug loading capacity and encapsulation efficiency are essential parameters that determine the therapeutic relevance and economic feasibility of polymeric nanoparticle formulations. High drug loading minimizes the amount of carrier material required, reducing formulation volume and potential toxicity. Encapsulation efficiency reflects the effectiveness of the formulation process in incorporating the drug within the nanoparticle matrix. These parameters are strongly influenced by polymer–drug compatibility, preparation technique, and processing conditions. Optimizing drug loading is particularly critical for potent drugs and macromolecules requiring precise dose control.

In Vitro Drug Release Behavior

In vitro drug release studies provide valuable information regarding the release mechanism and kinetics of polymeric nanoparticles. Drug release may occur through diffusion, polymer erosion, or a combination of both, depending on polymer composition and nanoparticle architecture. Controlled and sustained release profiles are often desirable to maintain therapeutic drug levels and reduce dosing frequency. In vitro release data also serve as an important predictor of in vivo performance and are routinely used for formulation comparison and optimization.

Stability Studies

Stability assessment is a crucial component of nanoparticle characterization, as it determines the shelf-life and clinical usability of the formulation. Polymeric nanoparticles must maintain their physicochemical properties, including particle size, drug content, and release behavior, under various storage conditions. Instability may arise from polymer degradation, particle aggregation, or drug leakage. Comprehensive stability studies support quality assurance, regulatory approval, and large-scale manufacturing.

Importance of Comprehensive Characterization

Thorough physicochemical characterization ensures a robust understanding of the behavior of polymeric nanoparticles in both in vitro and in vivo environments. Each parameter is interdependent, and variations in one attribute may significantly influence overall formulation performance. Comprehensive characterization not only supports rational formulation design but also plays a pivotal role in quality control, regulatory compliance, and successful clinical translation of polymeric nanoparticle-based drug delivery systems.

Table 5. Key Physicochemical Characterization Parameters of Polymeric Nanoparticles